fingolimod hydrochloride has been researched along with Benign Cerebellar Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brunetto, AL; Brunetto, AT; da Cunha Jaeger, M; da Silveira Perla, A; Dalmolin, MGS; de Farias, CB; Fratini, L; Roesler, R; Sinigaglia, M | 1 |
1 other study(ies) available for fingolimod hydrochloride and Benign Cerebellar Neoplasms
| Article | Year |
|---|---|
ZEB1 is a Subgroup-Specific Marker of Prognosis and Potential Drug Target in Medulloblastoma.
Topics: Adolescent; Brain Neoplasms; Cerebellar Neoplasms; Cerebellum; Child; Fingolimod Hydrochloride; Histone Deacetylase Inhibitors; Humans; Medulloblastoma; Zinc Finger E-box-Binding Homeobox 1 | 2023 |